Diabetes Care, Vol 17, Issue 12 1495-1497, Copyright © 1994 by American Diabetes Association

ARTICLES

Physicians' practices in screening for the development of diabetic nephropathy and the use of glycosylated hemoglobin levels

KL Miller and IB Hirsch
Department of Medicine, University of Washington School of Medicine, Seattle.

OBJECTIVE--To compare outpatient screening of diabetic patients for nephropathy and measurement of glycosylated hemoglobin (GHb) levels to published American Diabetes Association (ADA) guidelines. RESEARCH DESIGN AND METHODS--We reviewed charts from 157 diabetic patients followed for 27 months at the University of Washington's primary care clinics. The number of screening urinalyses, 24-h urine measurements, and GHb measurements were obtained. From these values, the frequency of screening tests, normalized by patient-year, could be compared with the ADA guidelines. RESULTS--Forty-two percent of the patients received at least one urinalysis, and 5% had 24-h urine measurements. There were 0.48 urinalyses and 0.05 24-h urine measurements per patient-year. Of 14 type I diabetes patients, 5 had a urinalysis and 1 received a 24-h urine measurement. At least one GHb was measured for 85% of patients, and there were 1.66 GHb measurements per patient-year. Only 29% of patients received GHb concentrations as recommended by ADA guidelines. CONCLUSIONS--Diabetic patients at this institution are not screened for nephropathy and do not receive GHb measurements according to the ADA guidelines. Because of recent advancements in the treatment of diabetic nephropathy and the results of the Diabetes Control and Complications Trial (DCCT), further efforts are needed for educating primary care physicians about standards of care of patients with diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. Bang, S. Vupputuri, D. A. Shoham, P. J. Klemmer, R. J. Falk, M. Mazumdar, D. Gipson, R. E. Colindres, and A. V. Kshirsagar SCreening for Occult REnal Disease (SCORED): A Simple Prediction Model for Chronic Kidney Disease Arch Intern Med, February 26, 2007; 167(4): 374 - 381. [Abstract] [Full Text] [PDF]

				S. B. Leichter The Coming Crisis in Continuing Education in Diabetes: Resolvable Issues and Novel Solutions Clin. Diabetes, January 1, 2005; 23(1): 6 - 8. [Full Text] [PDF]

				M. H. Chin, S. Cook, M. L. Drum, L. Jin, M. Guillen, C. A. Humikowski, J. Koppert, J. F. Harrison, S. Lippold, and C. T. Schaefer Improving Diabetes Care in Midwest Community Health Centers With the Health Disparities Collaborative Diabetes Care, January 1, 2004; 27(1): 2 - 8. [Abstract] [Full Text] [PDF]

				I. B. Hirsch The Burden of Diabetes (Care) Diabetes Care, May 1, 2003; 26(5): 1613 - 1614. [Full Text] [PDF]

				J. B. Brown, S. B Harris, S. Webster-Bogaert, S. Wetmore, C. Faulds, and M. Stewart The role of patient, physician and systemic factors in the management of type 2 diabetes mellitus Fam. Pract., August 1, 2002; 19(4): 344 - 349. [Abstract] [Full Text] [PDF]

				A. C. Larme and J. A. Pugh Evidence-Based Guidelines Meet the Real World: The case of diabetes care Diabetes Care, October 1, 2001; 24(10): 1728 - 1733. [Abstract] [Full Text] [PDF]

				M. H. Chin, S. Cook, L. Jin, M. L. Drum, J. F. Harrison, J. Koppert, F. Thiel, A. G. Harrand, C. T. Schaefer, H. T. Takashima, et al. Barriers to Providing Diabetes Care in Community Health Centers Diabetes Care, February 1, 2001; 24(2): 268 - 274. [Abstract] [Full Text]

				A.O. Phillips Diabetic nephropathy--where next? QJM, October 1, 2000; 93(10): 643 - 646. [Full Text] [PDF]